Abstract
As part of a large-scale study of menstrual blood loss in the community serum fibrin degradation products were measured soon after menstruation in 331 women. No significant correlation was found between the amount of blood lost and the serum level of fibrin degradation products. These findings conflict with reports suggesting that excessive intrauterine fibrinolysis, which may play a part in menorrhagia, is associated with raised serum F.D.P. concentrations.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Basu H. K. Fibrin degradation products in sera of women with normal menstruation and menorrhagia. Br Med J. 1970 Jan 10;1(5688):74–75. doi: 10.1136/bmj.1.5688.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheyne G. A., Shepherd M. M. Comparison of chemical and atomic absorption methods for estimating menstrual blood loss. J Med Lab Technol. 1970 Jul;27(3):350–354. [PubMed] [Google Scholar]
- Clarkson A. R., MacDonald M. K., Petrie J. J., Cash J. D., Robson J. S. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis. Br Med J. 1971 Aug;3(5772):447–451. doi: 10.1136/bmj.3.5772.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clarkson A. R., Morton J. B., Cash J. D. Urinary fibrin-fibrinogen degradation poducts after renal homotransplantation. Lancet. 1970 Dec 12;2(7685):1220–1223. doi: 10.1016/s0140-6736(70)92181-1. [DOI] [PubMed] [Google Scholar]
- Cole S. K., Billewicz W. Z., Thomson A. M. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw. 1971 Oct;78(10):933–939. doi: 10.1111/j.1471-0528.1971.tb00208.x. [DOI] [PubMed] [Google Scholar]
- Colman R. W., Braun W. E., Busch G. J., Dammin G. J., Merrill J. P. Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med. 1969 Sep 25;281(13):685–691. doi: 10.1056/NEJM196909252811301. [DOI] [PubMed] [Google Scholar]
- Das P. C., Allan A. G., Woodfield D. G., Cash J. D. Fibrin degradation products in sera of normal subjects. Br Med J. 1967 Dec 23;4(5581):718–720. doi: 10.1136/bmj.4.5581.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Das P. C. Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells. J Clin Pathol. 1970 Mar;23(2):149–155. doi: 10.1136/jcp.23.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HYTTEN F. E., CHEYNE G. A., KLOPPER A. I. IRON LOSS AT MENSTRUATION. J Obstet Gynaecol Br Commonw. 1964 Apr;71:255–259. doi: 10.1111/j.1471-0528.1964.tb04275.x. [DOI] [PubMed] [Google Scholar]
- Hoq M. S., Das P. C. Preparation of human cells for the assay of serum fibrinogen degradation products using haemagglutination inhibition. Scand J Haematol Suppl. 1971;13:101–105. doi: 10.1111/j.1600-0609.1971.tb01993.x. [DOI] [PubMed] [Google Scholar]
- Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
- NILSSON I. M., BJOERKMAN S. E. EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION. Acta Med Scand. 1965 Apr;177:445–457. [PubMed] [Google Scholar]
- Nilsson L., Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol. 1971 Jul 1;110(5):713–720. doi: 10.1016/0002-9378(71)90259-6. [DOI] [PubMed] [Google Scholar]
- Rybo G. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet Gynecol Scand. 1966;45(4):429–450. doi: 10.3109/00016346609158462. [DOI] [PubMed] [Google Scholar]